Skip to content

Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

Comparison of Two Immunosuppressive Regimens in Kidney Transplant Recipients With Deceased Donors With the Aim of Preventing the Development of Fibrosis / Atrophy of Reducing the Incidence of Cytomegalovirus Infection

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01353053
Enrollment
82
Registered
2011-05-12
Start date
2010-07-31
Completion date
Unknown
Last updated
2011-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cytomegalovirus Infections, Disorder of Transplanted Kidney

Keywords

Immunosuppression, Cytomegalovirus, Renal Transplant, Atrophy/interstitial, Conversion of tacrolimus everolimus

Brief summary

The aim of this the study is to the assess whether the graft and patient survival, rejection rates and renal graft function after the first year will not differ between both study arms. The investigators will also the evaluate the reduction in the incidence of cytomegalovirus the and improvement of renal function of the everolimus after 1 year.

Interventions

None listed

Sponsors

Federal University of São Paulo
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Patients with BMI below 30, * first transplants with PRA \< 30, * no contraindication for induction Thymoglobuline, * age 18 years or younger than 70 years.

Exclusion criteria

* patients with a BMI above 30 * retransplantation * patients hypersensitized with PRA \> 30 * compared with Thymoglobulina indication for induction * age under 18 or over 70 years

Countries

Brazil

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026